Comparative in vitro activities of TR-1710 and moxifloxacin against Mycobacterium kansasii

Comparative in vitro activities of TR-1710 and moxifloxacin against Mycobacterium kansasii

Bibliographic Details
Main Authors:	M. Cynamon, M. Sklaney, C. Shoen
Format:	Article
Language:	English
Published:	Elsevier 2014-04-01
Series:	International Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971214008972

Similar Items

Therapy for Mycobacterium kansasii Infection: Beyond 2018
by: Michelle S. DeStefano, et al.
Published: (2018-09-01)

Comparative Genomics and Transcriptomic Analysis of Mycobacterium Kansasii
by: Alzahid, Yara
Published: (2014)

Infección respiratoria por Mycobacterium kansasii
by: Raúl Vega Matos, et al.

Isolation and Characterization of Mycobacterium kansasii in Taiwan
by: Chen-Fu Lin, et al.
Published: (2004)

Activation of an NLRP3 inflammasome restricts Mycobacterium kansasii infection.
by: Chang-Chieh Chen, et al.
Published: (2012-01-01)

Treatment of pulmonary disease caused by Mycobacterium kansasii
by: Hung-Ling Huang, et al.
Published: (2020-06-01)

Disseminated Mycobacterium kansasii in an HIV-negative patient
by: Payam Tabarsi, et al.
Published: (2012-01-01)

Genomic Insights Into the Mycobacterium kansasii Complex: An Update
by: Tomasz Jagielski, et al.
Published: (2020-01-01)

Laryngeal Inflammatory Pseudotumour Secondary to Mycobacterium kansasii
by: Saif Al-Zahid, et al.
Published: (2018-01-01)

MOLECULAR TYPING OF MYCOBACTERIUM KANSASII — A GLOBAL PERSPECTIVE
by: Z. Bakuła, et al.
Published: (2018-12-01)

Osteomyelitis due to Mycobacterium kansasii in a patient with sarcoidosis
by: N. van Herwaarden, et al.
Published: (2017-01-01)

In-vitro evaluation of the antibacterial activity of the essential oils of Micromeria barbata, Eucalyptus globulus and Juniperus excelsa against strains of Mycobacterium tuberculosis (including MDR), Mycobacterium kansasii and Mycobacterium gordonae
by: Khaled El Omari, et al.
Published: (2019-09-01)

Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating Mycobacterium tuberculosis
by: Shashikant Srivastava, et al.
Published: (2021-01-01)

Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis
by: Min Qiao, et al.
Published: (2021-05-01)

Necrotizing pneumonia in a patient with untreated Mycobacterium kansasii infection
by: Amit Toor, et al.
Published: (2019-01-01)

Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens.
by: Seong Mi Moon, et al.
Published: (2015-01-01)

Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immunocompetent patient
by: Miaomiao Zhang, et al.
Published: (2017-09-01)

MALDI Spectra Database for Rapid Discrimination and Subtyping of Mycobacterium kansasii
by: Jayaseelan Murugaiyan, et al.
Published: (2018-04-01)

Comparative Genomic and Transcriptomic Analyses of Mycobacterium kansasii Subtypes Provide New Insights Into Their Pathogenicity and Taxonomy
by: Qingtian Guan, et al.
Published: (2020-03-01)

Natural killer cells play an important role in innate immunity against Mycobacterium kansasii infection
by: Tuan Yi Chang, et al.
Published: (2011)

Clinical Manifestations of Mycobacterium kansasii Infection and the Defense Mechanism of Host Natural Killer Cells against It
by: Ting Shu Wu, et al.
Published: (2016)

MKAN27435 is required for the biosynthesis of higher subclasses of lipooligosaccharides in Mycobacterium kansasii.
by: Vijayashankar Nataraj, et al.
Published: (2015-01-01)

Systemic <i>Mycobacterium kansasii</i> Infection in Two Related Cats
by: Petra Černá, et al.
Published: (2020-11-01)

Pulmonary infection caused by Mycobacterium kansasii: findings on computed tomography of the chest
by: Roberto Mogami, et al.

Spontaneous resolution of Mycobacterium kansasii presenting as a spiculated lung mass
by: Marwa Oudah, et al.
Published: (2021-01-01)

Extraction and biological evaluation of Mycobacterium kansasii extracellular vesicles as a vaccine candidate against mycobacterial pulmonary infections
by: Z Hoseini Tavassol, et al.
Published: (2017-05-01)

Molecular epidemiology and clinical characteristics of drug resistant Mycobacterium kansasii in Taiwan, 2000-2015
by: C. Hsu, et al.
Published: (2020-02-01)

A 16-year prospective survey of Mycobacterium xenopi, <it>Mycobacterium kansasii </it>and <it>Mycobacterium fortuitum </it>infection in patients with HIV disease
by: Manfredi Roberto
Published: (2010-05-01)

Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model
by: U D Gupta, et al.
Published: (2015-01-01)

Population genomics provides insights into the evolution and adaptation to humans of the waterborne pathogen Mycobacterium kansasii
by: Tao Luo, et al.
Published: (2021-05-01)

Evaluation of Mycobacterium kansasii extracellular vesicles role in BALB/c mice immune modulatory
by: Zahra Hoseini Tavassol, et al.
Published: (2020-01-01)

Molecular characterization of Mycobacterium kansasii isolates in the State of São Paulo between 1995-1998
by: Erica Chimara, et al.
Published: (2004-11-01)

The importance of computed tomography of the chest in cases of suspected infection with nontuberculous mycobacteria (Mycobacterium kansasii)
by: Miriam Menna Barreto, et al.

Genetic polymorphism and phenotypic resistance of Mycobacterium tuberculosis to ofloxacin and moxifloxacin
by: D. V. Vаkhrushevа, et al.
Published: (2020-12-01)

Pathogenic Determinants of the <i>Mycobacterium kansasii</i> Complex: An Unsuspected Role for Distributive Conjugal Transfer
by: Florian Tagini, et al.
Published: (2021-02-01)

Dynamics of Immune Responses during Experimental Mycobacterium kansasii Infection of Cynomolgus Monkeys (Macaca fascicularis)
by: Fangui Min, et al.
Published: (2018-01-01)

Short Communication: Subtyping of Mycobacterium kansasii by PCR-Restriction Enzyme Analysis of the hsp65 Gene
by: Zofia Bakuła, et al.
Published: (2013-01-01)

Chronic Tenosynovitis of the Upper Extremities Caused by Mycobacterium kansasii: A Clinical Case and Systematic Review of Literature
by: Maria T. Huayllani, et al.
Published: (2020-03-01)

A Study of the Predisposition for Mycobacterium Kansasii Infections in Dallas and Tarrant Counties Due to "Influenza-Like" Infections
by: Good, Willis E.
Published: (1978)

Ethambutol-resistant Mycobacterium kansasii cervical lymphadenitis in an immunocompetent adult patient: A case report and literature review
by: Víctor Asensi, et al.
Published: (2020-02-01)